|
ENAH expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.264600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.691000E-01 |
| Normal-vs-Stage2 |
7.282000E-01 |
| Normal-vs-Stage3 |
7.876200E-01 |
| Normal-vs-Stage4 |
9.351800E-01 |
| Stage1-vs-Stage2 |
8.121400E-01 |
| Stage1-vs-Stage3 |
6.712000E-01 |
| Stage1-vs-Stage4 |
3.818400E-01 |
| Stage2-vs-Stage3 |
9.204400E-01 |
| Stage2-vs-Stage4 |
6.690800E-01 |
| Stage3-vs-Stage4 |
7.122200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.718000E-01 |
| Normal-vs-AfricanAmerican |
7.747400E-01 |
| Normal-vs-Asian |
6.134600E-01 |
| Caucasian-vs-AfricanAmerican |
9.712800E-01 |
| Caucasian-vs-Asian |
4.385400E-01 |
| AfricanAmerican-vs-Asian |
6.059200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.641600E-01 |
| Normal-vs-Female |
6.171400E-01 |
| Male-vs-Female |
8.691400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.344600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.925400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.277000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.824450E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.495570E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.384100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.235400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.385400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.239600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.953800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.731800E-01 |
| Normal-vs-Grade 2 |
6.746200E-01 |
| Normal-vs-Grade 3 |
3.824000E-01 |
| Normal-vs-Grade 4 |
6.007800E-01 |
| Grade 1-vs-Grade 2 |
8.125400E-01 |
| Grade 1-vs-Grade 3 |
9.622600E-01 |
| Grade 1-vs-Grade 4 |
4.773200E-01 |
| Grade 2-vs-Grade 3 |
5.582200E-01 |
| Grade 2-vs-Grade 4 |
2.723200E-01 |
| Grade 3-vs-Grade 4 |
1.441590E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.709160E-01 |
| Normal-vs-ccB subtype |
2.799000E-01 |
| ccA subtype-vs-ccB subtype |
6.380900E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.330600E-01 |
| Normal-vs-N1 |
2.131000E-01 |
| N0-vs-N1 |
1.574970E-01 |
|
|
